Irmak Akarsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irmak Akarsu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Ali Celik
Department of Thoracic Surgery, Gazi University Faculty of Medicine, Ankara, Türkiye
7 shared publications - Muhammet Sayan
Department of Thoracic Surgery, Gazi University Faculty of Medicine, Ankara, Türkiye
7 shared publications - Ismail Cuneyt Kurul
Department of Thoracic Surgery, Gazi University School of Medicine, Ankara, Turkey
6 shared publications - Muhammet Tarik Aslan
Department of Thoracic Surgery, Gazi University, Ankara, Turkey
5 shared publications - Aysegul Kurtoglu
Department of Thoracic Surgery, Gazi University, Ankara, Turkey
4 shared publications - Gunel Ahmadova
Department of Thoracic Surgery, Gazi University School of Medicine, Ankara, Turkey
4 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (3) , 305-309
Comparison of subxiphoid and lateral intercostal approach in anterior mediastinal pathologies
The anterior mediastinum is the compartment where mediastinal lesions are most frequently seen. Both subxiphoid approaches (SVATS) and lateral intercostal approaches (LVATS) are used in anterior mediastinal lesions. In this study, we aimed to compare the outcomes and advantages of SVATS and LVATS. Between January 2013 and December 2024, the patients who underwent minimally invasive surgery for anterior mediastinal lesions were retrospectively analyzed. The study's main objectives were the characteristics of the patients, operation time, length of hospital stay, drain type, drain duration, postoperative complications, and visual analogue scale (VAS) analysis. A total of 79 patients were included in this study. Of these, 58.2% (n=46) cases were operated via LVATS and 41.8% (n=33) via SVATS. No significant difference was found in operation time, length of hospital stay, and complication. The most common postoperative complication was serous wound drainage. In one patient in the LVATS group, hence hemothorax was seen on postoperative day 1, revision surgery had to be done. Drain removal time was shorter in the subxiphoid group, but no statistical difference was found (p=0.059). In patients whose drain removal time was under 2 days, the length of hospital stay was also significantly shorter (p<0.001). The mean VAS was 2.24±1.25 in the SVATS group and 4.22±1.31 in the LVATS group. This study shows that SVATS significantly affected VAS. However, no süperiority was observed between SVATS and LVATS regarding operation time, length of hospital stay, and perioperative complications. Therefore, SVATS may be preferred over LVATS in anterior mediastinal lesions and may improve patients' quality of life with less pain.
- 10 April 2026
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 34 (3) , 305-309
Open AccessComparison of subxiphoid and lateral intercostal approach in anterior mediastinal pathologies
The anterior mediastinum is the compartment where mediastinal lesions are most frequently seen. Both subxiphoid approaches (SVATS) and lateral intercostal approaches (LVATS) are used in anterior mediastinal lesions. In this study, we aimed to compare the outcomes and advantages of SVATS and LVATS. Between January 2013 and December 2024, the patients who underwent minimally invasive surgery for anterior mediastinal lesions were retrospectively analyzed. The study's main objectives were the characteristics of the patients, operation time, length of hospital stay, drain type, drain duration, postoperative complications, and visual analogue scale (VAS) analysis. A total of 79 patients were included in this study. Of these, 58.2% (n=46) cases were operated via LVATS and 41.8% (n=33) via SVATS. No significant difference was found in operation time, length of hospital stay, and complication. The most common postoperative complication was serous wound drainage. In one patient in the LVATS group, hence hemothorax was seen on postoperative day 1, revision surgery had to be done. Drain removal time was shorter in the subxiphoid group, but no statistical difference was found (p=0.059). In patients whose drain removal time was under 2 days, the length of hospital stay was also significantly shorter (p<0.001). The mean VAS was 2.24±1.25 in the SVATS group and 4.22±1.31 in the LVATS group. This study shows that SVATS significantly affected VAS. However, no süperiority was observed between SVATS and LVATS regarding operation time, length of hospital stay, and perioperative complications. Therefore, SVATS may be preferred over LVATS in anterior mediastinal lesions and may improve patients' quality of life with less pain.
- Open Access
- 25 September 2025
- Published by Galenos Yayinevi in Gazi Medical Journal
Waldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma
Waldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma - Gazi Medical Journal
- 25 September 2025
- Published by Galenos Yayinevi in Gazi Medical Journal
Open AccessWaldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma
Waldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma - Gazi Medical Journal
- Open Access
- 14 May 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 77 (4) , 1215-1222
Predictive value of modified frailty index-5 to major complications after videothoracoscopic pulmonary resections
Although minimally invasive methods have become widespread, pulmonary resections due to lung cancer continue to be an important cause of postoperative morbidity. Herein, we have investigated the predicting efficacy of modified frailty index-5 (MFI-5) for postoperative complications in patients who underwent pulmonary resection by VATS for non-small cell lung cancer (NSCLC). We retrospectively reviewed the data of patients who underwent VATS lobectomy/segmentectomy for NSCLC. MFI-5 score was calculated according to hypertension, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, and functional independence status. Major postoperative complications were determined based on Clavien–Dindo classification. The predictive efficacy of MFI-5 score for major complications was tested by univariate and multivariate logistic regression analysis. A total of 336 patients were included in the study. The mean age was 65.6 ± 9.8 years. MFI-5 score was zero in 126 (37.5%) patients and positive in 210 patients. The major complication rate was 25.9%. Multivariate analysis showed that 2 and higher MFI-5 score significantly predicted the presence of postoperative major complications (p: 0.004, OR: 4.3, 1.58–12.5 95% CI). The MFI-5 score can significantly predict the presence of major postoperative complications, including 30-day mortality, in patients undergoing VATS pulmonary resection for NSCLC. Clinical registration 2024–324, approved by Gazi University Local Ethics Committee. Graphical abstract
- 14 May 2025
- Published by Springer Nature in Updates in Surgery
- Vol. 77 (4) , 1215-1222
Open AccessPredictive value of modified frailty index-5 to major complications after videothoracoscopic pulmonary resections
Although minimally invasive methods have become widespread, pulmonary resections due to lung cancer continue to be an important cause of postoperative morbidity. Herein, we have investigated the predicting efficacy of modified frailty index-5 (MFI-5) for postoperative complications in patients who underwent pulmonary resection by VATS for non-small cell lung cancer (NSCLC). We retrospectively reviewed the data of patients who underwent VATS lobectomy/segmentectomy for NSCLC. MFI-5 score was calculated according to hypertension, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, and functional independence status. Major postoperative complications were determined based on Clavien–Dindo classification. The predictive efficacy of MFI-5 score for major complications was tested by univariate and multivariate logistic regression analysis. A total of 336 patients were included in the study. The mean age was 65.6 ± 9.8 years. MFI-5 score was zero in 126 (37.5%) patients and positive in 210 patients. The major complication rate was 25.9%. Multivariate analysis showed that 2 and higher MFI-5 score significantly predicted the presence of postoperative major complications (p: 0.004, OR: 4.3, 1.58–12.5 95% CI). The MFI-5 score can significantly predict the presence of major postoperative complications, including 30-day mortality, in patients undergoing VATS pulmonary resection for NSCLC. Clinical registration 2024–324, approved by Gazi University Local Ethics Committee. Graphical abstract
- Open Access
- 30 October 2024
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 39 (5)
The prognostic significance of modified frailty index-5 in patients undergoing pneumonectomy for lung cancer
OBJECTIVES: In some centrally located lung cancers, complete excision of the mass cannot be achieved with parenchymal-sparing procedures and pneumonectomy may be required. The mortality and morbidity rates of pneumonectomy were reported to be considerably high. Here, we investigated the effectivity of modified frailty index-5 (MFI-5) in patients undergoing pneumonectomy for non-small cell lung cancer. METHODS: Data of patients who underwent pneumonectomy for non-small cell lung cancer between January 2018 and December 2023 were reviewed retrospectively. The MFI-5 score was determined by preoperative diabetes mellitus, hypertension, chronic obstructive pulmonary diseases, congestive heart failure and functional status. The effectiveness of the MFI-5 score for the presence of postoperative major complications and 30-day mortality was investigated by multivariate logistic regression analysis. A P-value <0.05 was considered statistically significant. RESULTS: A total of 107 patients who met the inclusion criteria were included in the study. Eight (7.5%) of patients were female, and the mean age was 61.4 ± 8.7. The MFI-5 score was 0 in 48 patients (44.9%), 1 in 27 patients (25.2%) and 2 in 20 patients (18.7%). Postoperative 30-day mortality was detected in 4 patients (3.7%), and the major complications occurred in 42 patients (39.3%). In multivariate analysis, an MFI-5 score of 2 or higher (P = 0.008, OR: 4.9) was statistically significant for complications, whereas age, gender, side of the operation, 0.05). CONCLUSIONS: The MFI-5 score is a significant indicator for predicting major postoperative events in patients who underwent pneumonectomy for non-small cell lung cancer. Clinical registration number: 2024-323, approved by Gazi University Local Ethics Committee.
- 30 October 2024
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 39 (5)
Open AccessThe prognostic significance of modified frailty index-5 in patients undergoing pneumonectomy for lung cancer
OBJECTIVES: In some centrally located lung cancers, complete excision of the mass cannot be achieved with parenchymal-sparing procedures and pneumonectomy may be required. The mortality and morbidity rates of pneumonectomy were reported to be considerably high. Here, we investigated the effectivity of modified frailty index-5 (MFI-5) in patients undergoing pneumonectomy for non-small cell lung cancer. METHODS: Data of patients who underwent pneumonectomy for non-small cell lung cancer between January 2018 and December 2023 were reviewed retrospectively. The MFI-5 score was determined by preoperative diabetes mellitus, hypertension, chronic obstructive pulmonary diseases, congestive heart failure and functional status. The effectiveness of the MFI-5 score for the presence of postoperative major complications and 30-day mortality was investigated by multivariate logistic regression analysis. A P-value <0.05 was considered statistically significant. RESULTS: A total of 107 patients who met the inclusion criteria were included in the study. Eight (7.5%) of patients were female, and the mean age was 61.4 ± 8.7. The MFI-5 score was 0 in 48 patients (44.9%), 1 in 27 patients (25.2%) and 2 in 20 patients (18.7%). Postoperative 30-day mortality was detected in 4 patients (3.7%), and the major complications occurred in 42 patients (39.3%). In multivariate analysis, an MFI-5 score of 2 or higher (P = 0.008, OR: 4.9) was statistically significant for complications, whereas age, gender, side of the operation, 0.05). CONCLUSIONS: The MFI-5 score is a significant indicator for predicting major postoperative events in patients who underwent pneumonectomy for non-small cell lung cancer. Clinical registration number: 2024-323, approved by Gazi University Local Ethics Committee.
- Open Access
- 22 October 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 58 (2) , 51-57
Recommendation for Clinical T Staging in Patients with Non-Small Cell Lung Cancer: Volumetric Measurement: A Retrospective Study from Turkey
Muhammet Sayan, M.D., Aykut Kankoc, M.D., Muhammet Tarik Aslan, M.D., Irmak Akarsu, M.D., İsmail Cuneyt Kurul, M.D., Ali Celik, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.24.052
- 22 October 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 58 (2) , 51-57
Open AccessRecommendation for Clinical T Staging in Patients with Non-Small Cell Lung Cancer: Volumetric Measurement: A Retrospective Study from Turkey
Muhammet Sayan, M.D., Aykut Kankoc, M.D., Muhammet Tarik Aslan, M.D., Irmak Akarsu, M.D., İsmail Cuneyt Kurul, M.D., Ali Celik, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.24.052
- Open Access
- 29 August 2023
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 1 (3) , 73-75
Preoperative spontaneous regression of type B2 thymoma in a patient with myasthenia gravis
Thymoma is the most common tumor of the anterior mediastinum. Spontaneous regression of thymoma is extremely rare. A 34-year-old female patient without any known disease, admitted by a myasthenic crisis, had a mass of 76 x 53 x 88 mm on thorax computed tomography (CT). The patient received intravenous immunoglobulin (IVIg) treatment for 5 days, pyridostigmine 60 mg/8 hours and prednisone 30 mg/day for the treatment of myasthenic crisis. Thorax CT on the 18th day showed that the mediastinal mass regressed to 63 x 30 x 63 mm. Histopathological analysis after extended thymectomy revealed the diagnosis of type B2 thymoma.
- 29 August 2023
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 1 (3) , 73-75
Open AccessPreoperative spontaneous regression of type B2 thymoma in a patient with myasthenia gravis
Thymoma is the most common tumor of the anterior mediastinum. Spontaneous regression of thymoma is extremely rare. A 34-year-old female patient without any known disease, admitted by a myasthenic crisis, had a mass of 76 x 53 x 88 mm on thorax computed tomography (CT). The patient received intravenous immunoglobulin (IVIg) treatment for 5 days, pyridostigmine 60 mg/8 hours and prednisone 30 mg/day for the treatment of myasthenic crisis. Thorax CT on the 18th day showed that the mediastinal mass regressed to 63 x 30 x 63 mm. Histopathological analysis after extended thymectomy revealed the diagnosis of type B2 thymoma.
- 29 June 2023
- Published by Springer Nature in Updates in Surgery
- Vol. 75 (8) , 2335-2342
Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
The optimum treatment option is surgery for clinical early stage non-small cell lung cancer. Despite all non-invasive and invasive staging effort, occult lymph-node metastasis can be detected in pathological staging. Here, we investigated whether there was any correlation between tumor diameter and occult lymph-node metastasis in N1 stations. Data of patient with non-small cell lung cancer clinical stage 1A were reviewed retrospectively. Those with tumor diameter smaller than 3 cm and pN0-pN1 in pathological staging were included in the study. Overall survival (OS) was calculated by Kaplan–Meier and survival differences between pN0 and pN1 groups were investigated by Log-Rank methods. Cut-off value of tumor diameter for lymph-node metastasis was investigated by Receiver-Operating Characteristics test. Significance between pN0-pN1 and other categorical groups was investigated with Pearson Chi-square or Fisher’s exact tests. A total of 257 patients meet to criteria included in the study. Fifty-five (21.4%) of the patients were females. The mean age was 62.7 ± 8.5 and median tumor diameter was 20 mm (Range: 2–30 mm). We detected occult lymph-node metastasis at the N1 stations (pN1) in 33 patients (12.8%) in histopathological examination of resected specimens and lymph-node dissection materials. The cut-off value of tumor diameter was calculated as 21.5 mm for occult lymph-node metastasis by Receiver-Operating Characteristics analysis (Area Under Curved: 70.1%, p = 0.004). There was a significant correlation between pN1 positivity and high tumor diameter (p = 0.02). However, we did not find a correlation between the lymph-node metastasis and age, gender, tumor histopathology, tumor localization, and visceral pleural invasion. Tumor diameter may be an indicator for occult lymph-node metastasis in patients with clinical stage-1A non-small cell lung cancer. This result should be considered in patient with mass which larger than 21.5 mm and planned stereotactic body radiotherapy instead of surgery. Graphical abstract
- 29 June 2023
- Published by Springer Nature in Updates in Surgery
- Vol. 75 (8) , 2335-2342
Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
The optimum treatment option is surgery for clinical early stage non-small cell lung cancer. Despite all non-invasive and invasive staging effort, occult lymph-node metastasis can be detected in pathological staging. Here, we investigated whether there was any correlation between tumor diameter and occult lymph-node metastasis in N1 stations. Data of patient with non-small cell lung cancer clinical stage 1A were reviewed retrospectively. Those with tumor diameter smaller than 3 cm and pN0-pN1 in pathological staging were included in the study. Overall survival (OS) was calculated by Kaplan–Meier and survival differences between pN0 and pN1 groups were investigated by Log-Rank methods. Cut-off value of tumor diameter for lymph-node metastasis was investigated by Receiver-Operating Characteristics test. Significance between pN0-pN1 and other categorical groups was investigated with Pearson Chi-square or Fisher’s exact tests. A total of 257 patients meet to criteria included in the study. Fifty-five (21.4%) of the patients were females. The mean age was 62.7 ± 8.5 and median tumor diameter was 20 mm (Range: 2–30 mm). We detected occult lymph-node metastasis at the N1 stations (pN1) in 33 patients (12.8%) in histopathological examination of resected specimens and lymph-node dissection materials. The cut-off value of tumor diameter was calculated as 21.5 mm for occult lymph-node metastasis by Receiver-Operating Characteristics analysis (Area Under Curved: 70.1%, p = 0.004). There was a significant correlation between pN1 positivity and high tumor diameter (p = 0.02). However, we did not find a correlation between the lymph-node metastasis and age, gender, tumor histopathology, tumor localization, and visceral pleural invasion. Tumor diameter may be an indicator for occult lymph-node metastasis in patients with clinical stage-1A non-small cell lung cancer. This result should be considered in patient with mass which larger than 21.5 mm and planned stereotactic body radiotherapy instead of surgery. Graphical abstract
- 1 February 2023
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 32 (1) , 8-12
Oxidized Regenerated Cellulose can be a Cause of False Tumor Recurrence on PET/CT in Patients with Lung Cancer Treated Surgically
Regular follow-up of patients with lung cancer treated surgically is crucial to detect local recurrence or distant metastasis of the tumor. Postoperative follow-ups are performed with thorax computed tomography (CT) and, if necessary, positron emission tomography (PET)/CT. Sometimes, inflammatory tissue reactions due to the materials used during the surgery for hemostasis may cause the appearance of tumor recurrence in imaging modalities. In this study, we presented that oxidized regenerated cellulose (ORC) used intraoperatively may cause false tumor recurrence on PET/CT. The records of patients who had local tumor recurrence after lung cancer surgery was reviewed retrospectively. Inclusion criteria were the presence of local recurrence of cancer on PET/CT, specification of using ORC in the surgical notes, and histopathological diagnosis of the recurrence site of tumor was reported as a foreign body reaction. Data of patients were collected according to age, gender, surgery performed, adjuvant therapy status, resolution status and time ORC, and standard uptake value of 18F-fluorodeoxyglucose on PET/CT. Eleven patients (1 female, 10 males) who met the criteria were included in the study. The median age was 64. Histopathological results of all patients were reported as foreign body reactions. The median detection time of PET/CT positivity after surgery was 139 days (range: 52-208 days). False tumor recurrence was resolved in 8 patients (72.7%) in their control radiological examinations and median resolution time was 334 days (range: 222-762 days). The median maximum standard uptake value of the lesions was 6.2 (1.7-11) on the PET/CT. ORC used intraoperatively in patients undergoing surgery for lung cancer may cause false tumor recurrence in imaging modalities in postsurgical follow-ups. When tumor recurrence is suspected in the follow-up of these patients, histopathological confirmation is necessary to prevent unnecessary operations and treatments.
- 1 February 2023
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 32 (1) , 8-12
Oxidized Regenerated Cellulose can be a Cause of False Tumor Recurrence on PET/CT in Patients with Lung Cancer Treated Surgically
Regular follow-up of patients with lung cancer treated surgically is crucial to detect local recurrence or distant metastasis of the tumor. Postoperative follow-ups are performed with thorax computed tomography (CT) and, if necessary, positron emission tomography (PET)/CT. Sometimes, inflammatory tissue reactions due to the materials used during the surgery for hemostasis may cause the appearance of tumor recurrence in imaging modalities. In this study, we presented that oxidized regenerated cellulose (ORC) used intraoperatively may cause false tumor recurrence on PET/CT. The records of patients who had local tumor recurrence after lung cancer surgery was reviewed retrospectively. Inclusion criteria were the presence of local recurrence of cancer on PET/CT, specification of using ORC in the surgical notes, and histopathological diagnosis of the recurrence site of tumor was reported as a foreign body reaction. Data of patients were collected according to age, gender, surgery performed, adjuvant therapy status, resolution status and time ORC, and standard uptake value of 18F-fluorodeoxyglucose on PET/CT. Eleven patients (1 female, 10 males) who met the criteria were included in the study. The median age was 64. Histopathological results of all patients were reported as foreign body reactions. The median detection time of PET/CT positivity after surgery was 139 days (range: 52-208 days). False tumor recurrence was resolved in 8 patients (72.7%) in their control radiological examinations and median resolution time was 334 days (range: 222-762 days). The median maximum standard uptake value of the lesions was 6.2 (1.7-11) on the PET/CT. ORC used intraoperatively in patients undergoing surgery for lung cancer may cause false tumor recurrence in imaging modalities in postsurgical follow-ups. When tumor recurrence is suspected in the follow-up of these patients, histopathological confirmation is necessary to prevent unnecessary operations and treatments.
- Open Access
- 13 December 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (6) , 2822-2826
The analysis of pleural complications of COVID-19 pneumonia
Background/aim: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia. Materials and methods: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of stay, treatment method for pleural complications, mortality, severity of COVID-19 pneumonia, tube thoracostomy duration, and presence of a mechanical ventilator. Results: A total of 31 patients fulfilling the inclusion criteria were included in the study. There were 11 female (35.5%) and 20 male (65.5%) patients. The most common complication was pneumothorax in 20 patients (65%). The median duration of hospitalization was 22 days and the mortality rate was 71%. Mortality was significantly higher in patients on mechanical ventilation (p = 0.04). Conclusion: The mortality rate is very high in patients with pleural complications of COVID-19 pneumonia. Pneumothorax is a fatal complication in critically ill patients with COVID-19 pneumonia.
- 13 December 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (6) , 2822-2826
Open AccessThe analysis of pleural complications of COVID-19 pneumonia
Background/aim: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia. Materials and methods: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of stay, treatment method for pleural complications, mortality, severity of COVID-19 pneumonia, tube thoracostomy duration, and presence of a mechanical ventilator. Results: A total of 31 patients fulfilling the inclusion criteria were included in the study. There were 11 female (35.5%) and 20 male (65.5%) patients. The most common complication was pneumothorax in 20 patients (65%). The median duration of hospitalization was 22 days and the mortality rate was 71%. Mortality was significantly higher in patients on mechanical ventilation (p = 0.04). Conclusion: The mortality rate is very high in patients with pleural complications of COVID-19 pneumonia. Pneumothorax is a fatal complication in critically ill patients with COVID-19 pneumonia.